This app is specifically intended for study participants in the STEP-1 study
The STEP-1 Study app is for data capture for the GI Dynamics Clinical Trial. The study is a randomized, multi-center, pivotal efficacy and safety study, evaluating the EndoBarrier® System for Glycemic Improvement in patients with inadequately controlled type 2 diabetes and obesity.
This app is specifically intended for study participants in the STEP-1 study.
Today’s rapidly changing healthcare landscape presents new challenges and disruptions to patient...
A Phase 3b/4, Randomized Study in Adults w/Obesity or Overweight w/Weight-Related Comorbidities...
This app is specifically intended for study participants in the Frontier4 (NN7769-4532)...
This app is specifically intended for study participants in the Bristol Myers...
You are invited to participate in the Bristol Myers Squibb CA116-001 study....
You are invited to participate in the Versanis VER201-PH2-031 study...
Created with AppPage.net
Similar Apps - visible in preview.